Chronic Pain Breakthrough, Ontario Drug Site Closure, and New COVID Variant BA.3.2

In this episode, Dr. Chi-Ming Chow delves into a range of topics. He explores a breakthrough in chronic back pain treatment and new research on parathyroid hormone. The episode also examines Ontario's decision to close supervised drug consumption sites and its public health implications. Dr. Chow updates listeners on the new COVID-19 variant BA.3.2 in the US and its potential impact. Additionally, he discusses the effects of the US oil embargo on the Cuban healthcare system and concludes with insights on the landmark trial against Meta and YouTube regarding social media addiction.